CA Stock MarketDetailed Quotes

Revive Therapeutics Ltd (RVV)

Watchlist
  • 0.015
  • 0.0000.00%
15min DelayMarket Closed Jan 15 14:48 ET
6.48MMarket Cap-0.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revive Therapeutics Ltd (RVV) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
69.70%-142.41K
76.67%-767.66K
97.82%-6.02K
95.48%-73.99K
75.37%-217.58K
5.14%-470.07K
45.39%-3.29M
51.36%-276.33K
24.18%-1.64M
-0.81%-883.42K
Net income from continuing operations
40.37%-281.75K
-95.98%-11.01M
-271.19%-9.6M
69.17%-577.18K
52.67%-364.71K
-20.96%-472.51K
11.11%-5.62M
-116.80%-2.59M
3.71%-1.87M
49.47%-770.62K
Operating gains losses
247.90%1.23K
-142.31%-73.85K
-35,763.54%-64.55K
-107.12%-12.41K
394.62%3.95K
-165.33%-833
10,727.85%174.55K
113.57%181
348,956.00%174.43K
-80.22%-1.34K
Depreciation and amortization
-25.81%46
-24.39%248
-24.39%62
-24.39%62
-24.39%62
-24.39%62
-24.42%328
-24.77%82
-24.07%82
-24.77%82
Asset impairment expenditure
----
300.00%9.38M
----
----
----
----
201.75%2.34M
----
----
----
Unrealized gains and losses of investment securities
--0
106.87%10.05K
-92.75%729
98.25%-2.74K
--6.03K
--6.03K
-267.18%-146.28K
-88.52%10.05K
---156.33K
--0
Remuneration paid in stock
--19.95K
-9.02%124.15K
--0
----
----
--0
--136.45K
--0
----
----
Other non cashItems
12,258.09%68.71K
5,367.70%201.92K
557.69%201.37K
--0
--0
-34.67%556
-97.90%3.69K
-5,318.98%-44K
-96.58%5.95K
5,816.64%40.88K
Change In working capital
1,564.81%49.41K
424.86%602.75K
4,203.89%74.9K
419.81%394.13K
189.94%137.09K
96.85%-3.37K
75.18%-185.54K
99.24%-1.83K
119.59%75.82K
-123.50%-152.42K
-Change in receivables
-34.66%-6.26K
96.74%20.95K
-77.79%12.85K
105.08%703
137.79%12.05K
-211.52%-4.65K
-82.17%10.65K
62.92%57.85K
30.94%-13.83K
-474.21%-31.88K
-Change in prepaid assets
-153.51%-32.18K
205.78%252.73K
105.25%11.52K
381.80%83.81K
453.12%97.27K
210.38%60.14K
-83,436.36%-238.91K
-1,461.17%-219.41K
9.11%17.39K
-16.14%17.59K
-Change in payables and accrued expense
198.86%87.85K
576.54%289.06K
-68.37%50.53K
314.65%299.63K
120.11%27.78K
-73.79%-88.86K
105.64%42.73K
154.84%159.73K
118.87%72.26K
-121.82%-138.13K
-Change in other working capital
----
--40K
--0
--10K
--0
--30K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
69.70%-142.41K
76.67%-767.66K
97.82%-6.02K
95.48%-73.99K
75.37%-217.58K
5.14%-470.07K
45.39%-3.29M
51.36%-276.33K
24.18%-1.64M
-0.81%-883.42K
Investing cash flow
Cash flow from continuing investing activities
0
-30K
0
0
0
-30K
0
40K
-40K
0
Net investment purchase and sale
--0
---30K
--0
--0
--0
---30K
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
---30K
--0
--0
--0
---30K
--0
--40K
---40K
--0
Financing cash flow
Cash flow from continuing financing activities
148.8K
-98.02%39.15K
35.38%-25.85K
-96.78%65K
0
0
-52.91%1.98M
-40K
-50.84%2.02M
0
Net issuance payments of debt
--0
197.88%39.15K
35.38%-25.85K
--65K
--0
--0
---40K
---40K
--0
--0
Net common stock issuance
--148.8K
--0
--0
----
----
--0
-48.38%2.02M
--0
----
----
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
--148.8K
-98.02%39.15K
35.38%-25.85K
-96.78%65K
--0
--0
-52.91%1.98M
---40K
-50.84%2.02M
--0
Net cash flow
Beginning cash position
-98.12%14.56K
-62.96%773.07K
-95.58%46.42K
-92.18%55.42K
-82.85%273K
-62.96%773.07K
-46.69%2.09M
-60.48%1.05M
-0.25%708.42K
0.34%1.59M
Current changes in cash
101.28%6.39K
42.29%-758.51K
88.47%-31.86K
-102.64%-8.99K
75.37%-217.58K
-0.92%-500.07K
28.11%-1.31M
51.36%-276.33K
-82.47%340.98K
-0.81%-883.42K
End cash Position
-92.33%20.95K
-98.12%14.56K
-98.12%14.56K
-95.58%46.42K
-92.18%55.42K
-82.85%273K
-62.96%773.07K
-62.96%773.07K
-60.48%1.05M
-0.25%708.42K
Free cash from
69.70%-142.41K
76.67%-767.66K
97.82%-6.02K
95.48%-73.99K
75.37%-217.58K
5.14%-470.07K
45.39%-3.29M
51.36%-276.33K
24.18%-1.64M
-0.81%-883.42K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 69.70%-142.41K76.67%-767.66K97.82%-6.02K95.48%-73.99K75.37%-217.58K5.14%-470.07K45.39%-3.29M51.36%-276.33K24.18%-1.64M-0.81%-883.42K
Net income from continuing operations 40.37%-281.75K-95.98%-11.01M-271.19%-9.6M69.17%-577.18K52.67%-364.71K-20.96%-472.51K11.11%-5.62M-116.80%-2.59M3.71%-1.87M49.47%-770.62K
Operating gains losses 247.90%1.23K-142.31%-73.85K-35,763.54%-64.55K-107.12%-12.41K394.62%3.95K-165.33%-83310,727.85%174.55K113.57%181348,956.00%174.43K-80.22%-1.34K
Depreciation and amortization -25.81%46-24.39%248-24.39%62-24.39%62-24.39%62-24.39%62-24.42%328-24.77%82-24.07%82-24.77%82
Asset impairment expenditure ----300.00%9.38M----------------201.75%2.34M------------
Unrealized gains and losses of investment securities --0106.87%10.05K-92.75%72998.25%-2.74K--6.03K--6.03K-267.18%-146.28K-88.52%10.05K---156.33K--0
Remuneration paid in stock --19.95K-9.02%124.15K--0----------0--136.45K--0--------
Other non cashItems 12,258.09%68.71K5,367.70%201.92K557.69%201.37K--0--0-34.67%556-97.90%3.69K-5,318.98%-44K-96.58%5.95K5,816.64%40.88K
Change In working capital 1,564.81%49.41K424.86%602.75K4,203.89%74.9K419.81%394.13K189.94%137.09K96.85%-3.37K75.18%-185.54K99.24%-1.83K119.59%75.82K-123.50%-152.42K
-Change in receivables -34.66%-6.26K96.74%20.95K-77.79%12.85K105.08%703137.79%12.05K-211.52%-4.65K-82.17%10.65K62.92%57.85K30.94%-13.83K-474.21%-31.88K
-Change in prepaid assets -153.51%-32.18K205.78%252.73K105.25%11.52K381.80%83.81K453.12%97.27K210.38%60.14K-83,436.36%-238.91K-1,461.17%-219.41K9.11%17.39K-16.14%17.59K
-Change in payables and accrued expense 198.86%87.85K576.54%289.06K-68.37%50.53K314.65%299.63K120.11%27.78K-73.79%-88.86K105.64%42.73K154.84%159.73K118.87%72.26K-121.82%-138.13K
-Change in other working capital ------40K--0--10K--0--30K----------------
Cash from discontinued investing activities
Operating cash flow 69.70%-142.41K76.67%-767.66K97.82%-6.02K95.48%-73.99K75.37%-217.58K5.14%-470.07K45.39%-3.29M51.36%-276.33K24.18%-1.64M-0.81%-883.42K
Investing cash flow
Cash flow from continuing investing activities 0-30K000-30K040K-40K0
Net investment purchase and sale --0---30K--0--0--0---30K--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0---30K--0--0--0---30K--0--40K---40K--0
Financing cash flow
Cash flow from continuing financing activities 148.8K-98.02%39.15K35.38%-25.85K-96.78%65K00-52.91%1.98M-40K-50.84%2.02M0
Net issuance payments of debt --0197.88%39.15K35.38%-25.85K--65K--0--0---40K---40K--0--0
Net common stock issuance --148.8K--0--0----------0-48.38%2.02M--0--------
Proceeds from stock option exercised by employees --------------------------0------------
Cash from discontinued financing activities
Financing cash flow --148.8K-98.02%39.15K35.38%-25.85K-96.78%65K--0--0-52.91%1.98M---40K-50.84%2.02M--0
Net cash flow
Beginning cash position -98.12%14.56K-62.96%773.07K-95.58%46.42K-92.18%55.42K-82.85%273K-62.96%773.07K-46.69%2.09M-60.48%1.05M-0.25%708.42K0.34%1.59M
Current changes in cash 101.28%6.39K42.29%-758.51K88.47%-31.86K-102.64%-8.99K75.37%-217.58K-0.92%-500.07K28.11%-1.31M51.36%-276.33K-82.47%340.98K-0.81%-883.42K
End cash Position -92.33%20.95K-98.12%14.56K-98.12%14.56K-95.58%46.42K-92.18%55.42K-82.85%273K-62.96%773.07K-62.96%773.07K-60.48%1.05M-0.25%708.42K
Free cash from 69.70%-142.41K76.67%-767.66K97.82%-6.02K95.48%-73.99K75.37%-217.58K5.14%-470.07K45.39%-3.29M51.36%-276.33K24.18%-1.64M-0.81%-883.42K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -